In addition, we confirmed the interaction between endogenous SMYD2 and β-catenin by co-immunoprecipitation assays in two cancer cell lines, HCT116 (colon cancer) and SNU475 (hepatocellular carcinoma (HCC)) (Figure 1E). Here, SMYD2 is linked to hepatocellular carcinoma.